Table 6.
Utility Values for Health States and Disutility Multipliers for Treatment-emergent Adverse Events
| Parameter | Value | Data Source | ||
| Health States | Full Adherence | Partial Adherence | Non-Adherence | |
| While Stable | 0.88 | 0.75 | 0.75 | Lenert et al., 2004 [76]; |
| Outpatient Relapse | 0.74 | 0.65 | 0.65 | Expert opinion |
| Inpatient Psychiatric Relapse | 0.53 | 0.53 | 0.42 | |
| Treatment-Emergent Adverse Events | ||||
| EPS | 0.888 | Lenert et al., 2004 [76] | ||
| Clinically Significant Weight Gain | 0.959 | |||
| Diabetes | 0.888 | Assumption: diabetes, hyperlipidemia, and Metabolic syndrome; | ||
| Hyperlipidemia | 0.888 | utilities equal EPS utility in Lenert et al., 2004 [76] | ||
EPS = extra-pyramidal symptoms